New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories (new zealand) limited - fluorescein 10%{relative} (converted to sodium fluorescein in situ) - solution for injection - 10 % - active: fluorescein 10%{relative} (converted to sodium fluorescein in situ) excipient: hydrochloric acid as 1n solution, to ph 9.0-9.8 sodium hydroxide as 1n solution, to ph 9.0-9.8 water for injection - diagnostic fluorescein angiography or angioscopy of the fundus and of the iris vasculature.

New Zealand - English - Medsafe (Medicines Safety Authority)

alcon laboratories australia pty ltd (nz) - fluorescein sodium 25%{relative} - solution for injection - 25 % - active: fluorescein sodium 25%{relative} excipient: hydrochloric acid as 1n solution, to ph 9.0-9.8 sodium hydroxide as 1n solution, to ph 9.0-9.8 water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - hydrocortisone butyrate 0.1%{relative} - topical cream - 0.1 % - active: hydrocortisone butyrate 0.1%{relative} excipient: butyl hydroxybenzoate cetomacrogol 1000 cetostearyl alcohol citric acid light liquid paraffin propyl hydroxybenzoate purified water sodium citrate white soft paraffin

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - hydrocortisone butyrate 0.1%{relative} - topical ointment - 0.1 % - active: hydrocortisone butyrate 0.1%{relative} excipient: plastibase

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - isotretinoin 0.05%{relative} (2% overage added);   - topical gel - 0.05% w/w - active: isotretinoin 0.05%{relative} (2% overage added)   excipient: butylated hydroxytoluene ethanol hyprolose - isotrex gel is indicated for the topical treatment of mild to moderate acne vulgaris, characterised by papules and pustules.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - paracetamol 2.4%{relative};  ;   - oral suspension - 120 mg/5ml - active: paracetamol 2.4%{relative}     excipient: amaranth citric acid monohydrate ethanol cherry flavour glycerol hydrogenated glucose syrup polysorbate 80 purified water saccharin sodium saponite sodium benzoate sorbitan oleate xanthan gum

New Zealand - English - Medsafe (Medicines Safety Authority)

obex medical ltd - iodised oil 38%{relative} (eqv to 48% w/v iodine);   - solution for injection - 38% w/w - active: iodised oil 38%{relative} (eqv to 48% w/v iodine)   - in diagnostic radiology lipiodol ultra fluid is used in lymphography, hysterosalpingography in women undergoing infertility workup and sialography.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - clioquinol 1%{relative};  ; flumetasone pivalate 0.02%{relative} - ear drops - active: clioquinol 1%{relative}   flumetasone pivalate 0.02%{relative} excipient: macrogol 300 - eczema of the external auditory meatus in which secondary infection with microorganisms sensitive to clioquinol has occurred. · otitis externa · otomycosis.

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - hydrocortisone butyrate 0.1%{relative} (1.5% overage);   - topical emulsion - 0.1% w/w - active: hydrocortisone butyrate 0.1%{relative} (1.5% overage)   excipient: borage oil butyl hydroxybenzoate butylated hydroxytoluene cetomacrogol cetostearyl alcohol citric acid hard paraffin propyl hydroxybenzoate propylene glycol purified water sodium citrate dihydrate white soft paraffin

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - clioquinol 1%{relative};  ; flumetasone pivalate 0.02%{relative} - ear drops - active: clioquinol 1%{relative}   flumetasone pivalate 0.02%{relative} excipient: macrogol 300 - eczema of the external auditory meatus in which secondary infection with micro-organisms sensitive to clioquinol has occurred. · otis externa · otomycosis